Pancytopenia
Bone Marrow
Red-Cell Aplasia, Pure
Lymphohistiocytosis, Hemophagocytic
Bone Marrow Cells
Bone Marrow Transplantation
Bone and Bones
Bone Remodeling
Prognostic significance of bone marrow biopsy in essential thrombocythemia. (1/338)
BACKGROUND AND OBJECTIVE: The diagnostic and prognostic value of bone marrow biopsy (BMB) has been widely investigated in patients with chronic myeloproliferative disorders (CMPD). The present study is based on a review of the results of routine BMBs taken from 93 essential thrombocythemia (ET) patients at the time of diagnosis. DESIGN AND METHODS: The common BMB histologic parameters and clinico-hematologic variables were considered for diagnostic and prognostic purposes. Clinico-pathologic correlations were looked for univariately. Moreover, the diagnostic significance of the histologic findings was tested by means of cluster analysis. Overall survival and event-free survival were considered as prognostic endpoints. RESULTS: There were no correlations between the clinic and pathologic findings, and none of the histologic and clinical parameters was predictive of survival or the occurrence of major clinical events. Cluster analysis of the BMB findings revealed two distinct morphologic patterns: one was clearly myeloproliferative; the other had somewhat dysplastic features. The event-free and overall survival rates in the latter group were significantly worse (p = 0.0377 and p = 0.0162 respectively), with major ischemic events accounting for most of the difference in event-free survival. INTERPRETATION AND CONCLUSIONS: These results have no clearcut counterpart in the literature, but we feel that dysplastic BMB findings could be included in the definition of ET prognostic scores in order to allow therapeutic strategies to be adapted to the level of risk. (+info)Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. (2/338)
PURPOSE: To study the prognostic value of plasmablastic morphology after autologous stem-cell transplantation for relapsed or primary refractory myeloma. PATIENTS AND METHODS: Seventy-five patients were studied. Investigators blinded to the clinical details of the individual cases reviewed bone marrow aspirate slides to determine plasmablastic classification. Plasmablasts were defined using strict, well-described criteria. Plasmablastic morphology was considered to be present (plasmablastic myeloma) when 2% or more plasmablasts were present in the plasma-cell population. RESULTS: Patients underwent transplantation 5 to 88 months (median, 20 months) after the initial diagnosis of myeloma. Twenty-eight percent of patients had plasmablostic morphology. A significantly greater proportion of patients with plasmablastic morphology had abnormal cytogenetics compared with those with nonplasmablastic classification (73% v 31%, respectively; P = .003). The overall survival rate measured from the time of transplantation was significantly worse in patients with plasmablastic morphology compared with those without (median survival time, 5 months v 24 months, respectively; P < .001). Progression-free survival time was shortened also, with a median time of 4 months compared with 12 months, respectively (P < .001). In the multivariate analysis, plasmablastic classification was the most powerful prognostic factor after transplantation for both overall (P = .001) and progression-free survival rates (P < .001). We also identified three risk groups based on plasmablastic morphology: plasma-cell labeling index, lactate dehydrogenase, and cytogenetics. The median overall survival time was 38 months when none of these factors was abnormal, 17 months with one abnormal factor, and 8 months with two or more abnormal factors (P < .001). CONCLUSION: Plasmablastic morphology is a powerful independent predictor of poor survival rate after autologous stem-cell transplantation for relapsed or primary refractory myeloma. (+info)Long-term toxicity of modified recombinant human tumor necrosis factor in Macaca mulatta. (3/338)
AIM: To study the long-term toxicity of modified recombinant human tumor necrosis factor (rhTNF-NC) in Macaca mulatta compared with recombinant human tumor necrosis factor (rhTNF). METHODS: rhTNF-NC 93, 9.3 GU/m2, and rhTNF 62 GU/m2 were injected i.v. daily to 16 Macaca mulatta for 1 month and 10 d, respectively. Hematologic, chemical, urinalysis values, ECG, specific antibody, bone marrow, and pathologic profile of organs were measured. RESULTS: No more adverse effects of rhTNF-NC were found in spite of anorexia in 4 monkeys and palpebral edema in 2 monkeys of 93 GU/m2 group. Besides, in rhTNF group, the injury of liver and kidneys, the decrease of erythron, the phlebitis, and thrombosis at injection site occurred. Both drugs caused the production of specific antibody. CONCLUSION: No serious adverse effects of rhTNF-NC were found in Macaca mulatta. The toxicity of rhTNF-NC was much lower than that of rhTNF. (+info)Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline. (4/338)
AIMS: To provide practical guidelines for the differentiation between benign and malignant focal lymphoid aggregates (lymphoid nodules) in routinely referred bone marrow trephine biopsies, using a synoptic approach including clinical data and histological workup. METHODS: For easy identification of very small lymphoid infiltrates the chloroacetate esterase stain was applied as a screening procedure. This allowed the identification of 491 formalin fixed, paraffin wax embedded specimens with one or more lymphoid nodules. Examination of lymphoid infiltrates included such variables as histotopography, demarcation, cytology, reticulin fibres, and immunohistochemistry with a set of monoclonal antibodies (CD20, CD45R, CD45R0, CD3, CD43). Evaluation of clinical and morphological data was carried out independently. In case of malignant lymphomas, a correlation with corresponding lymph node findings was made. RESULTS: 352 patients had benign focal lymphoid aggregates usually associated with systemic autoimmune diseases, chronic myeloproliferative disorders, toxic myelopathy, and viral infections. Discrete nodular infiltrates of (small cell) malignant lymphomas (n = 93) simulating benign hyperplasia were found in chronic lymphocytic leukaemia, germinal centre cell lymphomas (CB-CC), and lymphoplasmacytic/cytoid lymphomas (LPI). In addition to immunoreactivity, certain histological variables proved distinctive. These were: (1) histotopography, that is, localisation of the lymphoid aggregates within the bone marrow space; (2) relation to the surrounding tissue: margination or interstitial spillage of lymphoid cells; and (3) increase in reticulin fibres. CONCLUSIONS: A combined diagnostic procedure identifying several distinctive features, in particular histotopography and immunohistochemistry, provides a most promising way of discriminating reactive from neoplastic lymphoid nodules in the bone marrow. (+info)Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan. (5/338)
Dibromomannitol (DBM) is a new agent for the treatment of chronic granulocytic leukemia. A propsective evaluation of the drug was undertaken in a randomized comparison with busulfan. Forty previously untreated, Philadelphia chromosome-positive cases were treated, with 20 patients in each treatment group. The protocol provided for continuous maintenance therapy after remission induction, with a crossover to the opposite drug in patients who became refractory to the primary agent but are without evidence of blastic tranformation. There were 14 remissions in the DBM group and 15 in those treated with busulfan. The rate of decrease of the elevated leukocyte count was more rapid with DBM, but prolonged disease control off treatment occurred in only three of 14 cases as opposed to nine of fifteen busulfan-treated patients who required a median delay of 12 mo before maintenance could be initiated. Hypoplasia occurred in one DBM patient and two busulfan cases. Following recovery, crossover to the opposite drug in two cases again resulted in hypopllasia. Increased skin pigmentation, amenorrhea, pulmonary fibrosis, and cytologic dysplasia, commonly associated with busulfan adminstration, were also noted with DBM. The median duration of disease control with busulfan was 34 mo and 26 mo with DBM. There was no signigicant difference in the incidence of blastic transformation, and median survival for both groups was 44 mo. DBM appears to be as effective as busulfan in the treatment of the chronic phase of CGL but with a more predictable myelosuppressive action. The principal advantage of busulfan over DBM is the fact that more than half the busulfan-treated patients experienced prolonged disease control off treatment. (+info)De novo appearance of the ph-1 chromosome in a previously monosomic bone marrow (45,XX,-6): conversion of a myeloproliferative disorder to acute myelogenous leukemia. (6/338)
Bone marrow examination of a patient with a myeloproliferative disorder revealed monosomy for chromosome No. 6 (45,XX,-6). Two months later, during blastic crisis, reinvestigation of the bone marrow showed the presence of the Ph-1 chromosome in the previously aneuploid cell line (45,XX,-6,-22,+Ph-1). This case differs from those previously published in that the Ph-1 chromosome appeared de novo during the development of frank acute myelogenous leukemia. (+info)Functional and morphologic characteristics of the leukemic cells of a patient with acute monocytic leukemia: correlation with clinical features. (7/338)
The clinical course of a patient with acute monocytic leukemia and prominent infiltration of the skin and testes is described. In vitro studies demonstrated that the circulating monocyte precursors were capable of adherence to nylon fibers, and phagocytosis of bacteria and latex particles. In vivo, migration of leukemic cells to skin windows was observed. Extreme nuclear folding, marked surface activity, and morphologic features suggesting nuclear and cytoplasmic maturation were seen by light and electron microscopy. The presence of morphologically and functionally more differentiated monocytic cells may account for the marked tiuuse invasion in this patient and, possibly, in other patients with monocytic leukemia. (+info)Antitumor activity of thalidomide in refractory multiple myeloma. (8/338)
BACKGROUND: Patients with myeloma who relapse after high-dose chemotherapy have few therapeutic options. Since increased bone marrow vascularity imparts a poor prognosis in myeloma, we evaluated the efficacy of thalidomide, which has antiangiogenic properties, in patients with refractory disease. METHODS: Eighty-four previously treated patients with refractory myeloma (76 with a relapse after high-dose chemotherapy) received oral thalidomide as a single agent for a median of 80 days (range, 2 to 465). The starting dose was 200 mg daily, and the dose was increased by 200 mg every two weeks until it reached 800 mg per day. Response was assessed on the basis of a reduction of the myeloma protein in serum or Bence Jones protein in urine that lasted for at least six weeks. RESULTS: The serum or urine levels of paraprotein were reduced by at least 90 percent in eight patients (two had a complete remission), at least 75 percent in six patients, at least 50 percent in seven patients, and at least 25 percent in six patients, for a total rate of response of 32 percent. Reductions in the paraprotein levels were apparent within two months in 78 percent of the patients with a response and were associated with decreased numbers of plasma cells in bone marrow and increased hemoglobin levels. The microvascular density of bone marrow did not change significantly in patients with a response. At least one third of the patients had mild or moderate constipation, weakness or fatigue, or somnolence. More severe adverse effects were infrequent (occurring in less than 10 percent of patients), and hematologic effects were rare. As of the most recent follow-up, 36 patients had died (30 with no response and 6 with a response). After 12 months of follow-up, Kaplan-Meier estimates of the mean (+/-SE) rates of event-free survival and overall survival for all patients were 22+/-5 percent and 58+/-5 percent, respectively. CONCLUSIONS: Thalidomide is active against advanced myeloma. It can induce marked and durable responses in some patients with multiple myeloma, including those who relapse after high-dose chemotherapy. (+info)Bone marrow examination is a medical test that involves removing a sample of bone marrow from a patient's bone and examining it under a microscope. The bone marrow is the soft, spongy tissue found inside the bones, and it is responsible for producing blood cells, including red blood cells, white blood cells, and platelets. There are several different types of bone marrow examinations, including aspiration, biopsy, and trephination. During an aspiration, a small amount of bone marrow is removed using a needle and syringe. During a biopsy, a larger sample of bone marrow is removed using a biopsy needle. During trephination, a small piece of bone is removed, along with the bone marrow. Bone marrow examination is used to diagnose a variety of medical conditions, including anemia, leukemia, lymphoma, and multiple myeloma. It can also be used to monitor the effectiveness of treatment for these conditions, and to detect any complications that may arise during treatment.
Pancytopenia is a medical condition characterized by a decrease in all three types of blood cells: red blood cells (anemia), white blood cells (leukopenia), and platelets (thrombocytopenia). This can lead to a variety of symptoms, including fatigue, weakness, shortness of breath, bruising, and an increased risk of infections. Pancytopenia can be caused by a variety of factors, including bone marrow disorders, exposure to toxins, certain medications, and autoimmune diseases. Treatment for pancytopenia depends on the underlying cause and may include medications, blood transfusions, or bone marrow transplantation.
Bone marrow is a soft, spongy tissue found inside the bones of most mammals, including humans. It is responsible for producing blood cells, including red blood cells, white blood cells, and platelets. Red blood cells are responsible for carrying oxygen throughout the body, white blood cells help fight infections and diseases, and platelets are involved in blood clotting. The bone marrow is divided into two main types: red bone marrow and yellow bone marrow. Red bone marrow is responsible for producing all types of blood cells, while yellow bone marrow is primarily responsible for producing fat cells. In some cases, the bone marrow can be damaged or diseased, leading to conditions such as leukemia, lymphoma, or aplastic anemia. In these cases, bone marrow transplantation may be necessary to replace damaged or diseased bone marrow with healthy bone marrow from a donor.
Red-cell aplasia, pure, is a medical condition characterized by a decrease in the production of red blood cells (erythrocytes) in the bone marrow. In this condition, the bone marrow fails to produce enough red blood cells to meet the body's oxygen-carrying needs, leading to anemia. Pure red-cell aplasia is different from other forms of anemia because it affects only the production of red blood cells, while other forms of anemia may also involve a decrease in the production of white blood cells or platelets. The cause of pure red-cell aplasia can be idiopathic (unknown), or it may be associated with certain medical conditions, such as autoimmune disorders, infections, or exposure to certain medications or toxins. Symptoms of pure red-cell aplasia may include fatigue, weakness, shortness of breath, and pale skin. Treatment for pure red-cell aplasia typically involves administering red blood cell transfusions to replace the deficient red blood cells, as well as addressing any underlying medical conditions that may be contributing to the condition. In some cases, immunosuppressive therapy may be used to suppress the immune system and promote the production of red blood cells in the bone marrow.
Lymphohistiocytosis, hemophagocytic (LCH) is a rare disorder characterized by the accumulation of abnormal immune cells called histiocytes and lymphocytes in various tissues of the body. These cells can cause inflammation and damage to organs such as the liver, spleen, bone marrow, and central nervous system. One of the hallmark features of LCH is the presence of hemophagocytosis, which is the consumption of normal blood cells by the abnormal immune cells. This can lead to anemia, low platelet counts, and other complications. LCH can occur in both children and adults, and its symptoms can vary widely depending on the affected organs and the severity of the disease. Some common symptoms include fever, fatigue, weight loss, and swollen lymph nodes. There are several different types of LCH, including Letterer-Siwe disease (LS), Hand-Schüller-Christian disease (HSC), and eosinophilic granuloma complex (EGC). Treatment for LCH typically involves a combination of medications, such as corticosteroids, chemotherapy, and targeted therapies, depending on the type and severity of the disease.
Bone marrow cells are the cells found in the bone marrow, which is the soft, spongy tissue found in the center of bones. These cells are responsible for producing blood cells, including red blood cells, white blood cells, and platelets. There are two types of bone marrow cells: hematopoietic stem cells and progenitor cells. Hematopoietic stem cells are capable of dividing and differentiating into any type of blood cell, while progenitor cells are capable of dividing and differentiating into specific types of blood cells. In the medical field, bone marrow cells are often used in the treatment of blood disorders, such as leukemia and lymphoma, as well as in the transplantation of bone marrow to replace damaged or diseased bone marrow. In some cases, bone marrow cells may also be used in research to study the development and function of blood cells.
Bone marrow transplantation (BMT) is a medical procedure in which healthy bone marrow is transplanted into a patient who has damaged or diseased bone marrow. The bone marrow is the spongy tissue found inside bones that produces blood cells, including red blood cells, white blood cells, and platelets. There are two main types of bone marrow transplantation: autologous and allogeneic. Autologous BMT involves transplanting bone marrow from the patient's own body, usually after it has been harvested and stored before the patient undergoes high-dose chemotherapy or radiation therapy to destroy their diseased bone marrow. Allogeneic BMT involves transplanting bone marrow from a donor who is a genetic match for the patient. BMT is used to treat a variety of conditions, including leukemia, lymphoma, multiple myeloma, sickle cell anemia, and some inherited blood disorders. The procedure can also be used to treat certain immune system disorders and some genetic diseases. The success of BMT depends on several factors, including the type and stage of the patient's disease, the patient's overall health, and the availability of a suitable donor. The procedure can be complex and may involve several stages, including preparatory treatment, the actual transplantation, and post-transplantation care.
In the medical field, "bone and bones" typically refers to the skeletal system, which is made up of bones, cartilage, ligaments, tendons, and other connective tissues. The skeletal system provides support and structure to the body, protects vital organs, and allows for movement through the use of muscles. Bones are the main component of the skeletal system and are responsible for providing support and protection to the body. There are 206 bones in the human body, which are classified into four types: long bones, short bones, flat bones, and irregular bones. Long bones, such as the femur and humerus, are cylindrical in shape and are found in the arms and legs. Short bones, such as the carpals and tarsals, are cube-shaped and are found in the wrists and ankles. Flat bones, such as the skull and ribs, are thin and flat and provide protection to vital organs. Irregular bones, such as the vertebrae and pelvis, have complex shapes that allow for specific functions. Overall, the bone and bones of the skeletal system play a crucial role in maintaining the health and function of the human body.
Bone remodeling is a continuous process that occurs in the human body to maintain the strength and integrity of bones. It involves the coordinated activity of bone-forming cells called osteoblasts and bone-resorbing cells called osteoclasts. During bone remodeling, osteoclasts break down old or damaged bone tissue, releasing minerals and other components into the bloodstream. Osteoblasts then lay down new bone tissue to replace the old bone that was removed. This process of bone resorption followed by bone formation is a dynamic equilibrium that helps to maintain the balance between bone strength and bone density. Bone remodeling is influenced by a variety of factors, including hormones, mechanical stress, and age. For example, during childhood and adolescence, bone remodeling is stimulated by growth hormones and physical activity, leading to increased bone density and strength. In older adults, bone remodeling slows down, leading to a decrease in bone density and an increased risk of fractures. Disruptions in the bone remodeling process can lead to a variety of bone disorders, including osteoporosis, osteogenesis imperfecta, and Paget's disease. Understanding the mechanisms of bone remodeling is important for developing effective treatments for these conditions.
Bone marrow diseases refer to a group of disorders that affect the bone marrow, which is the spongy tissue inside bones that produces blood cells. The bone marrow produces red blood cells, white blood cells, and platelets, which are essential for the proper functioning of the immune system, oxygen transport, and blood clotting, respectively. There are several types of bone marrow diseases, including: 1. Leukemia: A type of cancer that affects the bone marrow and blood cells. It is characterized by the uncontrolled growth and division of abnormal white blood cells. 2. Lymphoma: A type of cancer that affects the lymphatic system, which is part of the immune system. It can also affect the bone marrow and produce abnormal white blood cells. 3. Myelodysplastic syndromes (MDS): A group of disorders that affect the bone marrow's ability to produce healthy blood cells. MDS can progress to leukemia. 4. Multiple myeloma: A type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies. It is characterized by the overproduction of abnormal plasma cells in the bone marrow. 5. Polycythemia vera: A type of blood disorder that causes the bone marrow to produce too many red blood cells. 6. Thalassemia: A group of genetic disorders that affect the production of hemoglobin, a protein found in red blood cells that carries oxygen throughout the body. Treatment for bone marrow diseases depends on the specific type and severity of the disorder. It may include chemotherapy, radiation therapy, stem cell transplantation, or supportive care to manage symptoms and complications.
Bone marrow examination
Heavy chain disease
Granulopoiesis
Prefibrotic primary myelofibrosis
Blood smear
Monoclonal gammopathy of undetermined significance
Marginal zone B-cell lymphoma
Plasma cell dyscrasias
Nucleated red blood cell
Latent iron deficiency
Chromosome 5q deletion syndrome
Non-Hodgkin lymphoma
Gabriel Rosenstock
Cerebroretinal microangiopathy with calcifications and cysts
Talaromyces marneffei
Carcinocythemia
Acute lymphoblastic leukemia
Autobiography of a Face
PDGFRB
Acute myeloid leukemia
Refractory cytopenia of childhood
Primary testicular diffuse large B-cell lymphoma
Dyskeratosis congenita
Biphenotypic acute leukaemia
Retinoblastoma
Romanowsky stain
Agranulocytosis
VEXAS syndrome
Bone marrow
Myeloproliferative neoplasm
Bone marrow examination - Wikipedia
Evans Syndrome Workup: Approach Considerations, Laboratory Studies, Bone Marrow Examination
Atlas of Bone Marrow pathology: Bone Marrow Examination
Bone Marrow Examination - Blood Disorders - MSD Manual Consumer Version
Bone Marrow Tests: MedlinePlus Medical Test
Platelet Disorders: Overview of Platelet Disorders, Pathophysiology of Platelet Disorders, Autoimmune Thrombocytopenias
Abstract: Indications and Spectrum of Haematological Disorders from Bone Marrow Aspiration Examination: A Three Year Review...
Figure 1 - Literature Review and Case Histories of Histoplasma capsulatum var. duboisii Infections in HIV-infected Patients -...
What Is Primary Hyperoxaluria Type 1 (PH1)? Life Expectancy
Advanced Search Results - Public Health Image Library(PHIL)
Emergence of the Ehrlichioses as Human Health Problems - Volume 2, Number 1-January 1996 - Emerging Infectious Diseases journal...
Page 1 | Search Results | Acta Haematologica | Karger Publishers
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group...
Severe Chronic Neutropenia - Symptoms, Causes, Treatment | NORD
Mouse Hematology: A Laboratory Manual
WHO EMRO | Review: Immune thrombocytopenia in children with reference to low-income countries | Volume 15, issue 3 | EMHJ...
Benzene | Public Health Statement | ATSDR
Myelodysplastic Syndromes - MDS: Diagnosis | Cancer.Net
RUH Pathology Services | Blood Test Information
Chelation Therapy - Medical Clinical Policy Bulletins | Aetna
Internal Medicine
Purinethol, 6Mercaptopurine (mercaptopurine) dosing, indications, interactions, adverse effects, and more
NIOSHTIC-2 Search Results - Full View
Malaria Surveillance -- United States, 1993
Bone Marrow Anatomy: Overview, Types of Bone Marrow, Blood Cell Formation
Bone Marrow Anatomy: Overview, Types of Bone Marrow, Blood Cell Formation
Blood Related Deficiencies in Cats | PetMD
Baby’s Pregnancy Calendar
Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type after biopsy - Indian Journal of...
Thrombocytopenia2
- Moreover, the presence of large platelets on the smear may suggest an immune etiology to the thrombocytopenia, while, in the presence of cytopenia, blood smear examination could help to rule out malignant disease or suggest the presence of one. (medscape.com)
- Bone marrow examination is usually not indicated in classic cases when patients present with autoimmune hemolytic anemia (AIHA) or immune thrombocytopenia. (medscape.com)
Aspiration removes1
- A bone marrow aspiration removes a sample of the fluid with a needle. (cancer.net)
Hypoplasia2
- Bone marrow studies may reveal erythroid hyperplasia and, occasionally, hypoplasia if AIHA is the predominant finding. (medscape.com)
- Bone marrow examination revealed intermittent hypoplasia without myelodysplasia or leukaemia. (karger.com)
Trephine biopsy4
- Bone marrow examination refers to the pathologic analysis of samples of bone marrow obtained by bone marrow biopsy (often called trephine biopsy) and bone marrow aspiration. (wikipedia.org)
- Bone marrow samples can be obtained by aspiration and trephine biopsy. (wikipedia.org)
- Frequently, a trephine biopsy is also obtained, which yields a narrow, cylindrically shaped solid piece of bone marrow, 2 mm wide and 2 cm long (80 μL), which is examined microscopically (sometimes with the aid of immunohistochemistry) for cellularity and infiltrative processes. (wikipedia.org)
- citation needed] Bone marrow aspiration and trephine biopsy are usually performed on the back of the hipbone, or posterior iliac crest. (wikipedia.org)
Microscopic Examination2
- Mouse Hematology presents a concise review of conventional methods for the preparation, enumeration, and microscopic examination of blood and blood-forming tissues of the laboratory mouse. (cshlpress.com)
- Also to include the microscopic examination of peripheral blood films and trephine bone marrow aspirates. (who.int)
Smear4
- Typical blood tests include a complete blood count (CBC), a reticulocyte count, examination of a blood smear, and the Coombs test (direct antiglobulin test). (medscape.com)
- Direct examination of bone marrow smear. (cdc.gov)
- Diagnosis is usually based on complete blood count and peripheral smear and, in selected cases, bone marrow aspiration. (who.int)
- The medical evaluation should include a blood smear examination for malaria. (cdc.gov)
Piece of bone2
- The needle is then advanced with a twisting motion and rotated to obtain a solid piece of bone marrow. (wikipedia.org)
- The core biopsy removes an entire piece of bone marrow and shows not only what cells are present but also how full the bone marrow is with cells and where the cells are located within the marrow. (msdmanuals.com)
Syringe4
- An aspiration, using a 20 mL syringe, yields approximately 300 μL of bone marrow. (wikipedia.org)
- Once the needle is in the marrow cavity, a syringe is attached and used to aspirate ("suck out") liquid bone marrow. (wikipedia.org)
- Although the aspirate often provides enough information for a diagnosis to be made, the process of drawing the marrow into the syringe breaks up the fragile bone marrow. (msdmanuals.com)
- The provider will push the needle into the bone and use a syringe attached to the needle to pull out bone marrow fluid and cells. (medlineplus.gov)
Biopsy needle3
- A small core of intact bone marrow is removed with a special bone marrow biopsy needle and sliced into thin sections that are examined under a microscope. (msdmanuals.com)
- The bone marrow biopsy uses a special hollow biopsy needle inserted through the same skin opening. (medlineplus.gov)
- We have compared the recently introduced Moeller Medical single use bone marrow core biopsy needle with the Jamshidi needle with marrow acquisition cradle (CareFusion), J-needle (Cardinal Health) and OnControl device (Vidacare). (bmj.com)
Tissue15
- are produced in the bone marrow, the soft fatty tissue inside bone cavities. (msdmanuals.com)
- Bone marrow is a soft, spongy tissue found in the center of most bones. (medlineplus.gov)
- The provider will twist the needle into the bone to take out a small piece, or core, of bone marrow tissue. (medlineplus.gov)
- A bone marrow biopsy is the removal of a small amount of solid tissue using a hollow needle. (cancer.net)
- The appearance of the bone marrow tissue, along with blood cell counts and chromosomal analysis (see below), is needed to confirm a diagnosis of MDS. (cancer.net)
- The hemorrhage and fat-tissue destruction in the marrow was apparently followed by a diffuse, and fatal, fat embolism. (cdc.gov)
- Bone marrow is the soft, spongy, gelatinous tissue found in the hollow spaces in the interior of bones. (medscape.com)
- Bone marrow consists of stem cells, which are large, "primitive," undifferentiated cells supported by fibrous tissue called stroma. (medscape.com)
- There are 2 main types of stem cells and, therefore, the bone marrow consists of 2 types of cellular tissue. (medscape.com)
- Bone marrow can be 1 of 2 types, red or yellow, depending on whether it consists of mainly hematopoietic (and therefore, red-colored) tissue or fatty (and therefore a yellow-colored) tissue. (medscape.com)
- The paraspinal abscess and the diseased in-tervertebral space tissue were taken for pathological examination during the operation. (scirp.org)
- The optimal clinical evaluation of the bone marrow requires an examination of air-dried and well-stained films of the aspirated tissue along with a histopathological evaluation of adequately processed and properly stained core biopsy specimens. (bmj.com)
- Biopsies involve getting bone marrow (with a needle) and/or small pieces of lymph node tissue for study with a microscope. (carle.org)
- The project, funded by the European Research Council , adapted magnetic resonance imaging (MRI) to non-invasively assess, in a single examination, the microstructure of both bone marrow and adipose tissue , comprised mainly of fat cells. (europa.eu)
- We are the first to use radiation-free CT-like MR imaging techniques in patient studies to simultaneously measure bone marrow and cortical bone tissue changes," says Karampinos. (europa.eu)
Aspirate7
- Sometimes, a bone marrow examination will include both an aspirate and a biopsy. (wikipedia.org)
- The aspirate yields semi-liquid bone marrow, which can be examined by a pathologist under a light microscope and analyzed by flow cytometry, chromosome analysis, or polymerase chain reaction (PCR). (wikipedia.org)
- An aspirate needle is inserted through the skin using manual pressure and force until it abuts the bone. (wikipedia.org)
- The bone marrow aspirate shows what cells, normal and abnormal, are present in the bone marrow and provides information about their size, volume, and other characteristics. (msdmanuals.com)
- Most (93.5%) of the marrow aspirate examined had definitive pathologic features while 4 (6.5%) were normal marrow elements. (cosmosscholars.com)
- ABSTRACT This study estimated the sensitivity and specificity of the rK39 strip test compared with the immunofluorescent antibody test and microscopy of bone marrow aspirate smears (the gold standard) in 47 children with suspected visceral leishmaniasis. (who.int)
- Samples for direct agglutination test (DAT) leishmaniasis by 3 different methods: light can be easily obtained, but must be sent microscopy of bone marrow aspirate to distant medical centres [ 9 ]. (who.int)
Chromosomes2
- Yearly bone marrow examinations where chromosomes are examined can detect leukemia at its earliest development. (rarediseases.org)
- Looking at the chromosomes of the cells in the blood and bone marrow shows specific abnormalities that help doctors tell the difference between MDS and other blood disorders. (cancer.net)
Megakaryocytes1
- The platelets arise from the fragmentation of the cytoplasm of megakaryocytes in the bone marrow and circulate in blood as disc-shaped anucleate particles for 7-10 days. (medscape.com)
Cytology1
- Bone marrow aspiration cytology records of 62 suspected cases of haematological diseases were reviewed and analyzed using STATA software version 10. (cosmosscholars.com)
Clinical1
- They are also translating their bone and bone marrow imaging techniques into clinical spine examinations, especially to assess fracture in patients with degenerative spine changes and bone metastases. (europa.eu)
Platelets5
- The bone marrow produces the cellular elements of the blood, including platelets, red blood cells and white blood cells. (wikipedia.org)
- Your health care provider may order a bone marrow aspiration and a bone marrow biopsy if other blood tests show your levels of red blood cells, white blood cells, or platelets are not normal. (medlineplus.gov)
- These stem cells divide to eventually give rise to red blood cells, platelets, and most white blood cells in the red marrow. (medscape.com)
- Similarly, the bone marrow produces and releases more white blood cells in response to infections, and it produces and releases more platelets in response to bleeding. (medscape.com)
- Bone marrow is vitally important for the production of blood cells, specifically red blood cells, white blood cells, and platelets. (allcreaturesanimalhosp.com)
Aplastic2
- Bone marrow aspiration helps to reveal aplastic anemia or an infiltrative disorder. (medscape.com)
- and immune-mediated diseases such as aplastic anemia, in which the bone marrow loses its ability to produce red-blood cells. (petmd.com)
Abnormalities1
- Bone marrow is commonly collected and examined when abnormalities are found in the circulating blood. (allcreaturesanimalhosp.com)
Iliac crest2
- Bone marrow samples are usually taken from the hipbone (iliac crest). (msdmanuals.com)
- Most bone marrow samples are taken from the back of the hip bone, called the iliac crest. (medlineplus.gov)
Disorders4
- The tests can help diagnose and monitor bone marrow disorders , blood disorders , and certain types of cancer . (medlineplus.gov)
- Hence, primary hemostatic disorders are characterized by prolonged bleeding time, and the characteristic physical examination findings are petechiae and purpura. (medscape.com)
- Haematological disorders have diverse modes of presentation that often requires bone marrow examination for both diagnosis and management. (cosmosscholars.com)
- A bone marrow evaluation can be essential in establishing a diagnosis, determining the efficacy of treatment in haematological disorders and to monitor haematological status of patients following bone marrow/stem cell transplantation. (bmj.com)
Tibia1
- In very young children, bone marrow samples are occasionally taken from one of the bones in the lower leg (tibia). (msdmanuals.com)
Diagnosis3
- In both cases bone marrow examinations revealed the typical criteria for myelodysplasia and this diagnosis was confirmed by cytogenetic analysis. (karger.com)
- The doctor will make a diagnosis from a medical history, physical examination, blood tests, and lymph gland and bone marrow biopsies. (carle.org)
- For decades, definite diagnosis of were patients with hepatosplenomegaly, visceral leishmaniasis has required in- fever, anaemia (with or without neutropae- vasive procedures to find the parasite in nia) or hypergammaglubolinaemia who had the organs, such as spleen, bone marrow, been referred from endemic regions. (who.int)
Femur1
- Gross examination revealed a hemorrhage in the bone marrow of the distal third of the left femur. (cdc.gov)
Chromosomal1
- Marrow karyotype revealed a clonal chromosomal abnormality which included trisomy 8 and absence of the Y chromosome. (karger.com)
Skin over the bone2
- A bone marrow sampling begins with cleaning, sterilizing, and anesthetizing the skin over the bone. (msdmanuals.com)
- An area of skin over the bone will be cleaned with an antiseptic. (medlineplus.gov)
Needle into the bone1
- After disinfecting the skin and numbing the area over the bone with a local anesthetic, the doctor inserts a needle into the bone and withdraws the marrow. (msdmanuals.com)
Abnormal3
- Sometimes a sample of bone marrow must be examined to determine why blood cells are abnormal or why there are too few or too many of a specific kind of blood cell. (msdmanuals.com)
- Your doctor may recommend running laboratory tests on a bone marrow sample to identify mutations in specific genes, abnormal proteins, and other factors unique to MDS. (cancer.net)
- The pathologist's report typically provides information about the health of the marrow, what types of cells are present, whether abnormal cells are found, and other details that may help to explain the patient's illness. (allcreaturesanimalhosp.com)
Procedure1
- The procedure takes a few minutes and causes no lasting damage to the bone. (msdmanuals.com)
Examine1
- These 2 procedures are done to examine the bone marrow. (cancer.net)
Stem Cell2
- Allogeneic bone marrow transplantation Allogeneic HSCT Allogeneic stem cell transplantation Myelodysplasia Stem Cell. (karger.com)
- Progenitor cell (stem cell) lines in the bone marrow produce new blood cells and stromal cells. (medscape.com)
Cases1
- However, in some cases, bone marrow examination may do nothing more than confirm that there is a problem. (allcreaturesanimalhosp.com)
Types1
- Both types of bone marrow are highly vascular, being enriched with numerous blood vessels and capillaries. (medscape.com)
Diseases1
- Other possible tests include urine analysis, immunologic tests for infections diseases like feline leukemia virus (FeLV), and a bone marrow examination. (petmd.com)
Hollow1
- Yellow marrow is found in the hollow interior of the diaphyseal portion or the shaft of long bones. (medscape.com)
Samples2
- A health care provider will collect the marrow samples for testing. (medlineplus.gov)
- You'll lie down on your side or your stomach, depending on which bone will be used to get the samples. (medlineplus.gov)
Blood cells9
- Bone marrow tests check to see if your bone marrow is working correctly and making normal amounts of blood cells. (medlineplus.gov)
- Too many or too few blood cells may mean you have a medical condition, such as cancer that starts in your blood or bone marrow. (medlineplus.gov)
- However, the yellow marrow can revert to red if there is increased demand for red blood cells, such as in instances of blood loss. (medscape.com)
- Bone marrow thus contains blood cells at varying stages of development. (medscape.com)
- Illustration of the pelvis to show the site of bone marrow and blood cells derived from bone marrow. (medscape.com)
- When the oxygen content of body tissues is low, if there is loss of blood or anemia, or if the number of red blood cells decreases, the kidneys produce and release erythropoietin, a hormone that stimulates the bone marrow to produce more red blood cells. (medscape.com)
- As age progresses, more of the red bone marrow turns into yellow bone marrow and the production of new blood cells becomes more difficult. (medscape.com)
- Medications for the underlying cause may be necessary, in addition to various medications to stimulate the production of neutrophils (a type of white blood-cell that fights infection), and another medication to stimulate the production of red-blood cells by bone marrow. (petmd.com)
- Urine examination revealed nephrotic-range proteinuria and 30-35 (mostly dysmorphic) red blood cells/high power field magnification. (ijpmonline.org)
Core1
- However, if a bone marrow core biopsy is concerned, several needles are currently in use but not all of them provide good-quality biopsy specimens for histological evaluation or are user friendly. (bmj.com)
Cells5
- Immunophenotyping is the examination of antigens, a specific type of protein, on the surface of the MDS cells. (cancer.net)
- Normally, only mature cells are released from the marrow into the bloodstream. (medscape.com)
- The bone marrow stroma contains mesenchymal stem cells. (medscape.com)
- The marrow fat was shown to differ depending on the age and sex of subjects, unlike the bone, suggesting complex pathophysiological influences on fat cells. (europa.eu)
- Examination of cells whether from a primary or secondary site, including fluids aspirated using endoscopes or needles. (who.int)
Physical2
- Daily physical examinations should be given after initial treatment, including frequent monitoring of body temperature and a periodic complete blood count (CBC). (petmd.com)
- General physical examination showed pallor and anasarca with pitting edema. (ijpmonline.org)
Needles1
- Currently available bone marrow aspiration needles are quite satisfactory and if properly used provide good-quality specimens for morphological evaluation. (bmj.com)
Test3
- Why do I need a bone marrow test? (medlineplus.gov)
- What happens during a bone marrow test? (medlineplus.gov)
- Le test sur bandelette au rK39 est fiable en l'absence de moyens de laboratoire. (who.int)
Patients4
- Majority of the patients who had bone marrow aspiration were adults aged 19 years and above. (cosmosscholars.com)
- All patients underwent X-ray, CT and MRI examinations. (scirp.org)
- All patients were confirmed by the above-mentioned comprehensive examination after admission. (scirp.org)
- Il s'agit d'une étude transversale, monocentrique et descriptive, durant 12 mois, incluant les patients âgés d'au moins 18 ans admis en réanimation polyvalente pour un sepsis ou choc septique. (bvsalud.org)
Disease1
- Severe or recurrent disease may need a bone marrow transplant. (carle.org)
Microscope1
- A drop of blood is placed on a glass microscope slide, smeared into a thin film, and placed under a microscope for examination. (cancer.net)
Solid1
- Bone marrow has both a solid and liquid part. (cancer.net)